INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 16
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Hims & Hers

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'The care you've always deserved'; 'Your weight loss breakthrough is here' - 'Lose up to 25% body weight with Wegovy'; 'The GLP-1 pill is here'. Page title: men's telehealth for hair, ED, weight loss, mental health.

Audienceread

Read: hims.com branded to men (title), mainstream consumers; brand-name FDA-approved emphasis.

Pricing & termsverified

GLP-1 medication from $199/mo (Wegovy pen, medication only); requires Hims Weight Loss Membership $39 first month then $149/mo, billed separately. Lineup: Wegovy pill/pen, Foundayo, Zepbound vial, Ozempic.

Clinical relationshipsverified

Physician-owned affiliated medical groups established with Hims & Hers support exclusively for its platform; not a named pooled third-party clinical network.

Pharmacy & fulfillmentverified

Majority fulfilled through wholly owned pharmacies (2025 10-K)

Advertising snapshotsnapshot

Google domain lookup (US, last 30 days): ~3K ads. Recent domain-result ads observed under US / Last 30 days. Domain results include multiple advertiser accounts, and may include non-GLP products. Hers separately: ~2K ads (observed page read). Do not sum as unique ads. sample last shown: Oct 11, 2026. Meta active exact-phrase keyword lookup: ~68 results. Active cards are present in the keyword result set; attribution to the brand is limited where content is age-gated.

Founding yearverified

2017

Founderspartial

Andrew Dudum; Hilary Coles; Jack Abraham; Joe Spector

Location & entity contextverified

2269 Chestnut Street #523, San Francisco, CA 94123 (principal executive office per 10-K)

Search visibility samplepartial

Free index sample: 3 domain-restricted pages and 3 brand+GLP results. Example pages: GLP-1 for Weight Loss: Everything You Need to Know; Tirzepatide Injectable – Hims, Inc.; Ozempic® Alternatives for Weight Loss. No appearance in the checked 15-result samples for GLP-1 online weight loss, compounded semaglutide online, and compounded tirzepatide online.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.